%201.png)
%201.svg)
Two Thirds of Adults Are Overweight or Obese
Obesity has become one of the most pressing public health challenges facing the UK. Approximately 30% of adults are classified as obese, while a further 36% are overweight, meaning that two-thirds of the adult population falls outside the healthy weight range. This represents a dramatic increase from 1993, when just 15% of the population was obese or overweight. In three decades, the prevalence of excess weight has more than quadrupled.
This epidemic is not merely an aesthetic concern; obesity is a serious medical condition associated with multiple chronic diseases, reduced quality of life, and increased mortality. The economic burden on the NHS and the broader economy is substantial and growing.
Key Facts & Figures (Overview)
- 30% of UK adults are obese
- 36% of UK adults are overweight
- 66% of UK adults are overweight or obese combined
- In 1993, only 15% of the population was overweight or obese
- Ultra-processed foods (UPF) comprise 57% of the average UK diet
- Portion sizes have increased by up to 50% in the last 30 years
- Sedentary behaviour and reduced physical activity are major contributing factors
- Obesity is more prevalent in lower socioeconomic groups due to cost of healthy foods
- Type 2 diabetes: 90% of cases are linked to obesity
- Obesity significantly increases the risk of cardiovascular disease
- Obesity is linked to increased risk of 13 types of cancer
- The NHS spends approximately £6.5 billion annually on obesity-related care
- The total economic cost of obesity to society is estimated at £27 billion annually
- GLP-1 receptor agonist drugs (such as semaglutide/Ozempic) have emerged as a significant new treatment option
What Is Obesity?
Obesity is clinically defined using Body Mass Index (BMI), calculated as weight in kilograms divided by height in metres squared (kg/m²). The WHO and NHS classifications are as follows:
- Underweight: BMI less than 18.5
- Healthy weight: BMI 18.5 to 24.9
- Overweight: BMI 25 to 29.9
- Obese (Class I): BMI 30 to 34.9
- Obese (Class II): BMI 35 to 39.9
- Severely Obese (Class III): BMI 40 or above
The Causes of Obesity
Ultra-Processed Foods (UPF): Ultra-processed foods comprise approximately 57% of the average UK diet. These foods are engineered to be hyper-palatable, high in calories, low in nutritional value, and designed for maximum consumption. They are cheaper and more convenient than whole foods, making them attractive to budget-conscious consumers. However, they contribute significantly to caloric excess and poor nutritional intake.
Portion Sizes: Over the past 30 years, portion sizes have increased dramatically. A standard serving in a restaurant or convenience food package is often substantially larger than official dietary guidelines recommend. Consumers have become accustomed to oversized portions, leading to excessive caloric intake.
Sedentary Behaviour: Modern lifestyles involve significantly more sedentary time compared to previous decades. Office-based work, screen time, and reliance on motorised transport have reduced daily energy expenditure. Physical education in schools has also been deprioritised in many areas.
Socioeconomic Factors: Obesity is more prevalent in lower socioeconomic groups. Healthy, whole foods are often more expensive per calorie than ultra-processed alternatives. Lower-income families may lack access to affordable fresh produce, safe spaces for physical activity, and time for food preparation. Food insecurity and obesity often coexist, a phenomenon known as the "hunger-obesity paradox."
Childhood Obesity
The National Child Measurement Programme (NCMP) provides the most comprehensive data on childhood obesity. Current findings are alarming: approximately 10% of Reception-aged children (4-5 years old) are already classified as obese. By Year 6 (10-11 years old), this figure increases to 22.7%, with an additional 14.4% classified as overweight. This means that more than 37% of children leaving primary school are either overweight or obese. These children face an increased lifetime risk of obesity-related diseases and complications.
Obesity and Diet-Related Disease
Type 2 Diabetes: Approximately 90% of Type 2 diabetes cases are linked to obesity. The condition develops when excess body weight impairs insulin function, leading to hyperglycaemia. Type 2 diabetes increases the risk of cardiovascular disease, kidney disease, neuropathy, and blindness.
Cardiovascular Disease: Obesity significantly increases the risk of heart disease, stroke, and hypertension. Excess body weight increases strain on the heart and arteries, and obesity is associated with dyslipidaemia and inflammation.
Cancer: Obesity is associated with increased risk of at least 13 types of cancer, including breast cancer (post-menopausal), endometrial cancer, oesophageal cancer, and colorectal cancer. The mechanisms involve hormonal changes, chronic inflammation, and impaired immune function.
The Cost of Obesity to the NHS
The financial burden of obesity on the NHS is extraordinary. The service spends approximately £6.5 billion annually on direct obesity-related care, including treatment of diabetes, cardiovascular disease, cancer, and obesity management interventions. The broader economic cost to society, including lost productivity, reduced life expectancy, and healthcare expenses beyond the NHS, is estimated at £27 billion annually. This represents an unsustainable drain on resources that could be redirected to other healthcare priorities.
Recently, GLP-1 receptor agonist drugs (such as semaglutide, marketed as Ozempic for diabetes and Wegovy for weight loss) have emerged as a significant new treatment option. These medications, originally developed for diabetes management, have demonstrated remarkable efficacy in weight loss. However, their high cost and limited availability mean they remain inaccessible to most patients, raising questions about equity and the long-term sustainability of pharmaceutical solutions to an epidemic rooted in systemic food and lifestyle factors.
Written by Food Safety Experts
This article was written by the team at Level 2 Food Hygiene, specialists in food safety training and compliance.
